Preservation of beta-cell function in type 2 diabetes mellitus
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Glibenclamide; Insulin aspart/insulin protamine aspart; Metformin; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 14 Dec 2017 Biomarkers information updated
- 22 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Aug 2011 Planned End Date changed from 1 Apr 2011 to 1 Nov 2011 as reported by ClinicalTrials.gov.